Canonical ingredient
canagliflozin
CANAGLIFLOZIN
22 linked products
Official identifiers
CAS 842133-18-0ChEBI CHEBI:73274InChI InChI=1S/C24H25FO5S/c1-13-2-3-15(24-23(29)22(28)21(27)19(12-26)30-24)10-16(13)11-18-8-9-20(31-18)14-4-6-17(25)7-5-14/h2-10,19,21-24,26-29H,11-12H2,1H3/t19-,21-,22+,23-,24+/m1/s1InChIKey XTNGUQKDFGDXSJ-ZXGKGEBGSA-NSMILES [H][C@@]1(c2ccc(C)c(Cc3ccc(-c4ccc(F)cc4)s3)c2)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
Names and synonyms
- canagliflozin (en)
- Canagliflozine (fr)
Safety and technical documents
General references and manufacturer-specific SDS documents are kept separate.
No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.
End-to-end traceability
Only links supported by an identified source are published. Missing evidence remains explicitly unknown.
Evidence still missing
- Country or region of origin
- Raw-material producer
- Ingredient manufacturer
- Distributor
- Transformation steps
Documented origins
No origin has been proven yet by an explicit source.
Documented organizations
No organization has been proven yet by an explicit source.
Documented transformations
No transformation step has been proven yet by an explicit source.
Method: a company’s registration country is never used as evidence of a material’s origin.
Products containing this ingredient
AG-CANAGLIFLOZIN
100 · MG
AG-CANAGLIFLOZIN
300 · MG
APO-CANAGLIFLOZIN
100 · MG
APO-CANAGLIFLOZIN
300 · MG
AURO-CANAGLIFLOZIN
100 · MG
AURO-CANAGLIFLOZIN
300 · MG
INVOKAMET
50 · MG
INVOKAMET
50 · MG
INVOKAMET
50 · MG
INVOKAMET
150 · MG
INVOKAMET
150 · MG
INVOKAMET
150 · MG
INVOKAMET XR
50 · MG
INVOKAMET XR
50 · MG
INVOKAMET XR
150 · MG
INVOKAMET XR
150 · MG
INVOKANA
100 · MG
INVOKANA
300 · MG
JAMP CANAGLIFLOZIN
100 · MG
JAMP CANAGLIFLOZIN
300 · MG
SANDOZ CANAGLIFLOZIN
100 · MG
SANDOZ CANAGLIFLOZIN
300 · MG